Labetalol: A Descriptive Analysis of Adverse Events Reported in the FDA Adverse Event Reporting System (FAERS)

Ähnliche Einträge

• Descriptive Analysis of Ranolazine Adverse Events Reported in the FDA Adverse Event Reporting System (FAERS)
  von: Nehad Jaser Ahmed
  Veröffentlicht: (2026)
• Descriptive Analysis of DALTEPARIN Adverse Events Reported in the FDA Adverse Event Reporting System (FAERS)
  von: Nehad Jaser Ahmed
  Veröffentlicht: (2026)
• DOFETILIDE Descriptive Analysis of Adverse Events Reported in the FDA Adverse Event Reporting System (FAERS)
  von: Nehad Jaser Ahmed
  Veröffentlicht: (2026)
• Prazosin Adverse Events: A Descriptive Analysis of the FDA Adverse Event Reporting System (FAERS)
  von: Nehad Jaser Ahmed
  Veröffentlicht: (2026)
• HYDROCHLOROTHIAZIDE ADVERSE EVENTS A Descriptive Analysis of Adverse Events Reported in the FDA Adverse Event Reporting System (FAERS)
  von: Nehad Jaser Ahmed
  Veröffentlicht: (2026)